IR Information
About Our Company
Our Vision
Management
Corporate Information
Our History
About Our Business
Business Model
R&D Pipelines
News
Policy
Privacy Policy
Anonymously Processing Informations
IR News
IR News
Management Information
IR Library
Other IR Information
FAQ
Japanese
TOP
>
IR News
IR News
2026.05.14
Timely Disclosure
Preliminary Results of the XPRIZE Healthspan Semi-Final Clinical Trial
(1MB)
2026.05.13
Financial Statements
Non-consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (Under Japanese GAAP)
(202KB)
2026.05.13
Timely Disclosure
Notice of Differences Between Full-Year Earnings Forecasts and Actual Results for the Fiscal Year Ended March 2026
(174KB)
2026.05.12
Timely Disclosure
Announcement of Initiation of a Phase II Trial for Unresectable Pancreatic Cancer with Distant Metastasis or Recurrent Pancreatic Cancer
(274KB)
2026.04.24
Timely Disclosure
Announcement of the initiation of a phase II trial for locally advanced non-small cell lung cancer
(158KB)
IR News List
Management Information
To Our Shareholders and Investors
Corporate Governance
IR Library
IR Library List
Financial Results
Presentation Materials
General Meeting of Shareholders Materials
Timely Disclosure Information
Other IR Information
Stock Information
IR Calendar
Disclosure Policy
Disclaimer
IR Contact
For IR inquiries, please contact us here.